Entities / Company
Ideaya Biosciences (United States).
company in South San Francisco, United States
- Reports this week
- 0
- Active events
- 1
- Connections
- 34
What's happening
Active this week
Gone quiet
No new reports in 90+ days-
Ideaya Biosciences utilized Nasdaq listing rules for stock option grants on August 29, 2025.Some support2 reports1 development inside
-
Ideaya Biosciences' stock options were priced based on the Nasdaq closing price on June 27, 2025.Speculative1 report
-
Ideaya Biosciences and Hengrui Pharmaceuticals presented data on IDE849, with Hengrui conducting a Phase 1 trial in China.Some support1 report
-
Ideaya Biosciences presented data on its drug darovasertib for melanoma at the ESMO meeting in Berlin.Some support1 report
-
Ideaya Biosciences adhered to Nasdaq Listing Rule 5635(c)(4) on August 1, 2025.Some support1 report
-
Ideaya Biosciences presented data at an event hosted by Cleveland Clinic on August 18, 2025.Some support1 report
-
Ideaya Biosciences featured a Key Opinion Leader (KOL) from Cleveland Clinic on August 25, 2025.Some support1 report
-
Ideaya Biosciences presented data at a congress in Amsterdam on August 30, 2025.Some support1 report
-
Gilead Sciences is collaborating with Ideaya Biosciences, providing Trodelvy supply to support clinical trials.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Ideaya Biosciences (United States) this week
News at the entities that move Ideaya Biosciences (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Ideaya Biosciences (United States)
-
Gilead Sciences StructuralRequired regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Moves Ideaya Biosciences (United States)
-
Cleveland Clinic OperationalNewsweek included in global ranking and ranks hospitals in Malaysia.Moves Ideaya Biosciences (United States)
Connections
The 3 strongest of 34, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Ideaya Biosciences relies on the FDA for regulatory designations and clearance of its clinical trials.
-
Gilead Sciences Structural
Gilead supplies Trodelvy to Ideaya Biosciences, and the companies are collaborating on clinical trials.
-
Cleveland Clinic Operational
Ideaya Biosciences presents research data and features Key Opinion Leaders associated with Cleveland Clinic.
History
Events by the month they beganJune 2026
10 events- Servier and Ideaya Biosciences entered an exclusive license agreement on September 2, 2025.
- Ideaya Biosciences utilized Nasdaq listing rules for stock option grants on August 29, 2025.
- Ideaya Biosciences' stock options were priced based on the Nasdaq closing price on June 27, 2025.
- Ideaya Biosciences and Hengrui Pharmaceuticals presented data on IDE849, with Hengrui conducting a Phase 1 trial in China.
- Ideaya Biosciences presented data on its drug darovasertib for melanoma at the ESMO meeting in Berlin.
- Ideaya Biosciences adhered to Nasdaq Listing Rule 5635(c)(4) on August 1, 2025.
- Ideaya Biosciences presented data at an event hosted by Cleveland Clinic on August 18, 2025.
- Ideaya Biosciences featured a Key Opinion Leader (KOL) from Cleveland Clinic on August 25, 2025.
- Ideaya Biosciences presented data at a congress in Amsterdam on August 30, 2025.
- Gilead Sciences is collaborating with Ideaya Biosciences, providing Trodelvy supply to support clinical trials.